<Disease><Name>PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1</Name><Synonym>DOPAMINE TRANSPORTER DEFICIENCY SYNDROME; DTDS</Synonym><OMIM><Number>613135</Number><URL>http://omim.org/entry/613135</URL></OMIM><Orphanet><Number>238455</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=238455</URL></Orphanet><Protein><Number>Sodium-dependent dopamine transporter</Number><URL>https://www.uniprot.org/uniprot/Q01959</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>5p15.33</Gene><ICD /><Summary>rare;autosomal recessive;mutation in the SLC6A3 gene;- early onset (infancy);- later onset (childhood - adulthood)</Summary><Symptoms><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1983</id><symptom>constipation</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3982</id><symptom>drooling</symptom><category>HEAD</category></symtomp><symtomp><id>2457</id><symptom>dyskinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1724</id><symptom>eye movements, abnormal</symptom><category>EYES</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3970</id><symptom>gastroesophageal reflux / GER</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2513</id><symptom>oculogyric crisis</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1970</id><symptom>pyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value /><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7597</id><title>Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family</title><author>Heidari E,</author><journal>Ann Hum Genet</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>7598</id><title>SLC6A3-Related Dopamine Transporter Deficiency Syndrome</title><author>Kurian MA</author><journal>GeneReviews&#174; [Internet]</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>7599</id><title>Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood</title><author>Ng J,</author><journal>Brain</journal><year>2014</year><book /><volume>137</volume><number>4</number><pages>1107-1119</pages><co_aut>et al.</co_aut></literature><literature><id>7600</id><title>SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking</title><author>Bowton E,</author><journal>Transl Psychiatry</journal><year>2014</year><book /><volume>4</volume><number>0</number><pages>e464</pages><co_aut>et al.</co_aut></literature><literature><id>7594</id><title>Genetic mapping and exome sequencing identify variants associated with five novel diseases</title><author>Puffenberger EG,</author><journal>PLoS One</journal><year>2012</year><book /><volume>7</volume><number>1</number><pages>E28936</pages><co_aut>et al.</co_aut></literature><literature><id>7595</id><title>The monoamine neurotransmitter disorders: an expanding range of neurological syndromes</title><author>Kurian MA,</author><journal>Lancet Neurol</journal><year>2011</year><book /><volume>10</volume><number>8</number><pages>721-733</pages><co_aut>et al.</co_aut></literature><literature><id>7596</id><title>Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia</title><author>Kurian MA,</author><journal>J Clin Invest</journal><year>2009</year><book /><volume>119</volume><number>6</number><pages>1595-1603</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>